Get a free book sample
August 13, 2020 — GIDEON’s mission is to provide robust support to clinicians, microbiologists, and educators who interface with the infectious diseases field. As such, consulting with our users when developing the product is paramount to ensuring that GIDEON continues to meet their expectations. On 12th August, GIDEON closed its last alpha testing round, dedicated to gathering feedback on the brand new ‘Diagnose’ module. Medical experts from 26 countries have explored the new interface and shared their thoughts on what works and what can be improved.
Alpha is an early release of a major product upgrade. Our first alpha testing round was focused on displaying our extensive database in a brand new ‘Explore’ module. The second one was geared toward clinicians who may use GIDEON in Point-of-Care settings to diagnose infectious diseases.
The comments were overwhelmingly positive. Here are some of them:
We are so grateful for all the positivity and constructive criticism – it will improve the product for everyone.
A full beta release is currently planned for mid-September. It’s the same GIDEON data that you know and love, but like you’ve never seen before! The beta will include our brand new Lab module, designed to assist microbiologists. Check out a sneak peek below:
GIDEON is one of the most well-known and comprehensive global databases for infectious diseases. Data is refreshed daily, and the GIDEON API allows medical professionals and researchers access to a continuous stream of data. Whether your research involves quantifying data, learning about specific microbes, or testing out differential diagnosis tools– GIDEON has you covered with a program that has met standards for accessibility excellence.